References
- Bastias AM, Toro CL, Olmos CP. Intensified insulin therapy plus antineuritic medication is more effective than antineuritics alone in painful diabetic neuropathy. Rev Med Chil 2006; 134: 1507–1515
- Beydoun S, Alarcon F, Mangat S, Wan Y. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 2007; 115: 284–288
- Ambrosch A, Dierkes J, Lobmann R, Kuhne W, Konig W, Luley C, Lehnert H. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 2001; 18: 185–192
- Christianson JA, Ryals JM, Johnson MS, Dobrowsky RT, Wright DE. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 2007; 145: 303–313
- Donnan J, Ledger S. An update on the treatment and management of diabetic peripheral neuropathy. CANNT J 2006; 16: 32–36
- Edwards JL, Vincent AM, Cheng HL, Feldman EL. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 2008; 120: 1–34
- Foster TS. Efficacy and safety of α-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ 2007; 33: 111–117
- Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol 2003; 16: 522–534
- Hvas AM, Ellegaard J, Nexo E. Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem 2001; 47: 1396–1404
- Ide H, Fujiya S, Asanuma Y, Tsuji M, Sakai H, Agishi Y. Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clin Ther 1987; 9: 183–192
- Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 2002; 17: 916–922
- Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, Hattori T. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999; 38: 472–475
- Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006; 29: 340–344
- Moron de Salim AR, Garces PA. Effect of the supplementation of vitamins B12, B6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV. Arch Latinoam Nutr 2005; 55: 28–33
- Pongchaidecha M, Srikusalanukul V, Chattananon A, Tanjariyaporn S. Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: A cross-sectional study in patients with type 2 diabetes mellitus. J Med Assoc Thai 2004; 87: 780–787
- Sanchez Alvarez JE, Perez TL, Hernandez D, Alvarez GA, Delgado P, Lorenzo V. Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial. Nefrologia 2005; 25: 288–296
- Stracke H, Lindemann A, Federlin K. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 1996; 104: 311–316
- Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: Systematic review of clinical controlled trials. Acta Neurol Taiwan 2005; 14: 48–54
- Yaqub BA, Siddique A, Sulimani R. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 1992; 94: 105–111